Dartmouth Health Children’s Pediatric Lecture Series - Updates in Pediatric Allergy

Wednesday, May 21, 2025, 8:00 AM - Sunday, May 21, 2028, 9:00 AM

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

This Pediatric Lecture Series will discuss important pediatric topics that may lead to the improvement of child health from an individual, health care system and/or societal level. This presentation provides information on screening, diagnosis and treatment options for pediatric patients with allergies.

Presenter

Sarah A. Taylor-Black, MD
Allergy & Clinical Immunology
Dartmouth-Hitchcock Clinic, Concord, NH.

Dr. Taylor-Black attended Brown University School of Medicine and graduated 2007 and then went to New York-Presbyterian Hospital for Residency in Internal Medicine 2010 and Mount Sinai Medical Center for Allergy/Immunology Fellowship 2012. She joined Dartmouth in 2012 out of fellowship and was at DH Keene for four years before transitioning to Concord and Bedford.

1. Describe recent updates in medications for pediatric allergy and asthma management.
2. Identify new therapies available for managing pediatric food allergy.
3. Explain recent updates in atopic dermatitis management with regards to food allergies.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hours.

All other learners may claim CME-designated participation credit. Consult your professional licensing board regarding the applicability and acceptance of CME-designated participation credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.

2. Register for the activity.

3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.

4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).

5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.

6. Complete and Submit the Evaluation.

Bibliographic Material

• Su, Chun-Hung, et al. "Cumulative dose effects of H1 antihistamine use on the risk of dementia in patients with allergic Rhinitis." The Journal of Allergy and Clinical Immunology: In Practice 12.8 (2024): 2155-2165.

• Lindqvist, Magnus, et al. "Natural course of pollen?induced allergic rhinitis from childhood to adulthood: A 20?year follow up." Allergy 79.4 (2024): 884-893.

• Yu Y, Cao W, Xiao Y, et al.  Pediatr Pulmonol. 2023;58(12):3406-15.

• Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention (“LEAP-Trio”) Du Toit G, Huffaker MF, Radulovic S, et al. (No relevant disclosures) NEJM Evid. 2024;3(6):EVIDoa2300311.

• Du Toit, George, et al. "Randomized trial of peanut consumption in infants at risk for peanut allergy." New England Journal of Medicine 372.9 (2015): 803-813.

• Mack et al J Allergy Clin Immunol 2024;153: 1621-33

• Wood, Robert A., et al. "Omalizumab for the treatment of multiple food allergies." New England Journal of Medicine 390.10 (2024): 889-899.

• Casale, Thomas B., et al. "Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection." Journal of Allergy and Clinical Immunology 152.6 (2023): 1587-1596.

• Chang, Angela, et al. "Natural history of food-triggered atopic dermatitis and development of immediate reactions in children." The Journal of Allergy and Clinical Immunology: In Practice 4.2 (2016): 229-236.

• Oykhman, Paul, et al. "Dietary elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis." The Journal of Allergy and Clinical Immunology: In Practice 10.10 (2022): 2657-2666.
  

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.